SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001544227-21-000007
Filing Date
2021-02-09
Accepted
2021-02-09 16:36:37
Documents
1
Period of Report
2021-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_161290656696722.html 3  
1 FORM 3 wf-form3_161290656696722.xml 3 12461
  Complete submission text file 0001544227-21-000007.txt   13919
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 MILLER AVENUE SUITE 100 ANN ARBOR MI 48104
Business Address
Minai-Azary Jennifer Lynn (Reporting) CIK: 0001844398 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35890 | Film No.: 21607047